Indication
Kidney Disease
19 clinical trials
21 products
2 drugs
Clinical trial
A Phase 2, Open-label, Multicenter Study of Mitapivat in Subjects With Sickle Cell Disease and NephropathyStatus: Not yet recruiting, Estimated PCD: 2026-05-01
Product
MitapivatClinical trial
Phase II, Open-label, Randomized, Multiple Ascending Dose Confirmation of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation (BASTION)Status: Recruiting, Estimated PCD: 2024-12-16
Clinical trial
A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseStatus: Terminated, Estimated PCD: 2022-11-01
Product
PlaceboProduct
NitazoxanideClinical trial
An Open-label, Phase 1, Multiple-dose Study to Evaluate the Pharmacokinetics of Nitazoxanide 500 mg Twice Daily for 7 Days in Adult Subjects With Mild, Moderate, and Severe Renal Impairment and Adult Healthy Control SubjectsStatus: Completed, Estimated PCD: 2022-09-04
Product
BrincidofovirProduct
GFB-887Product
VenetoclaxClinical trial
Evaluation of the Pharmacokinetics and Safety of Venetoclax in Subjects With Impaired Renal FunctionStatus: Completed, Estimated PCD: 2022-08-16
Clinical trial
An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney DiseasesStatus: Terminated, Estimated PCD: 2022-11-02
Clinical trial
A Phase 2a, Open-label, Single-arm, 2-Part Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-147 in Adults With APOL1-mediated Focal Segmental GlomerulosclerosisStatus: Completed, Estimated PCD: 2021-11-11
Product
VX-147Product
CCX140-BClinical trial
A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Focal Segmental Glomerulosclerosis (FSGS)Status: Completed, Estimated PCD: 2020-02-19
Clinical trial
BKVIR Project: Predictive Biological Method of BKvirus Associated Nephropathy Risk by the NEPHROVIR MethodStatus: Active (not recruiting), Estimated PCD: 2023-09-02
Clinical trial
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy: a Multicenter, Randomized, Open-label, Parallel Controlled StudyStatus: Recruiting, Estimated PCD: 2027-05-03
Product
Huaier granuleProduct
CiclosporinClinical trial
Autonomic and Renal Contributions to Hypertension With Androgen Deprivation TherapyStatus: Recruiting, Estimated PCD: 2028-03-31
Product
Androgen receptor inhibitorClinical trial
APOL1 Genetic Testing in African Americans: Exploring Attitudes About Genetic Risk to Improve Comprehensive Kidney Risk Assessment for Patients and FamiliesStatus: Recruiting, Estimated PCD: 2025-06-30
Product
APOL-1 renal risk variantClinical trial
Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic SyndromeStatus: Completed, Estimated PCD: 2022-12-30
Product
DandshenClinical trial
IMPROVE-T2D Study: Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 DiabetesStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Product
Aminohippurate SodiumProduct
IohexolClinical trial
A Prospective, Randomized Trial Comparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Cardiac CatheterizationStatus: Terminated, Estimated PCD: 2010-04-08
Product
N-AcetylcysteineProduct
Sodium BicarbonateClinical trial
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyStatus: Active (not recruiting), Estimated PCD: 2023-06-30
Clinical trial
Prevention of CKD Progression in Type 1 Diabetes With Long Term Use of SGLTi Avoiding Kidney hypOxia(PLUTO)Status: Not yet recruiting, Estimated PCD: 2026-06-01
Product
SotagliflozinDrug
VarlilumabClinical trial
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer PatientsStatus: Recruiting, Estimated PCD: 2023-03-01
Drug
CisplatinClinical trial
Novel Extragonadal Effects of Human Chorion Gonadotropin (hCG) on Calcium HomeostasisStatus: Completed, Estimated PCD: 2022-10-31
Product
Human Chorionic Gonadotropin